chr6-160706093-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000484367.5(PLG):n.706G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 377,368 control chromosomes in the GnomAD database, including 10,689 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.21 ( 3911 hom., cov: 32)
Exomes 𝑓: 0.23 ( 6778 hom. )
Consequence
PLG
ENST00000484367.5 non_coding_transcript_exon
ENST00000484367.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0600
Publications
8 publications found
Genes affected
PLG (HGNC:9071): (plasminogen) The plasminogen protein encoded by this gene is a serine protease that circulates in blood plasma as an inactive zymogen and is converted to the active protease, plasmin, by several plasminogen activators such as tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman factor). The conversion of plasminogen to plasmin involves the cleavage of the peptide bond between Arg-561 and Val-562. Plasmin cleavage also releases the angiostatin protein which inhibits angiogenesis. Plasmin degrades many blood plasma proteins, including fibrin-containing blood clots. As a serine protease, plasmin cleaves many products in addition to fibrin such as fibronectin, thrombospondin, laminin, and von Willebrand factor. Plasmin is inactivated by proteins such as alpha-2-macroglobulin and alpha-2-antiplasmin in addition to inhibitors of the various plasminogen activators. Plasminogen also interacts with plasminogen receptors which results in the retention of plasmin on cell surfaces and in plasmin-induced cell signaling. The localization of plasminogen on cell surfaces plays a role in the degradation of extracellular matrices, cell migration, inflamation, wound healing, oncogenesis, metastasis, myogenesis, muscle regeneration, neurite outgrowth, and fibrinolysis. This protein may also play a role in acute respiratory distress syndrome (ARDS) which, in part, is caused by enhanced clot formation and the suppression of fibrinolysis. Compared to other mammals, the cluster of plasminogen-like genes to which this gene belongs has been rearranged in catarrhine primates. [provided by RefSeq, May 2020]
PLG Gene-Disease associations (from GenCC):
- hypoplasminogenemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- angioedema, hereditary, 4Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 6-160706093-G-A is Benign according to our data. Variant chr6-160706093-G-A is described in ClinVar as [Benign]. Clinvar id is 1247104.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.285 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.209 AC: 31756AN: 151986Hom.: 3916 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31756
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.225 AC: 50690AN: 225264Hom.: 6778 Cov.: 0 AF XY: 0.216 AC XY: 25792AN XY: 119280 show subpopulations
GnomAD4 exome
AF:
AC:
50690
AN:
225264
Hom.:
Cov.:
0
AF XY:
AC XY:
25792
AN XY:
119280
show subpopulations
African (AFR)
AF:
AC:
709
AN:
7130
American (AMR)
AF:
AC:
1346
AN:
9066
Ashkenazi Jewish (ASJ)
AF:
AC:
1681
AN:
6514
East Asian (EAS)
AF:
AC:
5
AN:
12460
South Asian (SAS)
AF:
AC:
3042
AN:
31046
European-Finnish (FIN)
AF:
AC:
3496
AN:
13468
Middle Eastern (MID)
AF:
AC:
216
AN:
882
European-Non Finnish (NFE)
AF:
AC:
37219
AN:
132176
Other (OTH)
AF:
AC:
2976
AN:
12522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1722
3444
5166
6888
8610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.209 AC: 31750AN: 152104Hom.: 3911 Cov.: 32 AF XY: 0.204 AC XY: 15173AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
31750
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
15173
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
4245
AN:
41510
American (AMR)
AF:
AC:
2985
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1001
AN:
3466
East Asian (EAS)
AF:
AC:
10
AN:
5184
South Asian (SAS)
AF:
AC:
489
AN:
4822
European-Finnish (FIN)
AF:
AC:
2700
AN:
10562
Middle Eastern (MID)
AF:
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
AC:
19579
AN:
67962
Other (OTH)
AF:
AC:
472
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1249
2499
3748
4998
6247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
165
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.